 |
 |
Dear all, next year's CCP4 Study Weekend will be held at the East Midlands Conference Centre, Nottingham University, 8-10th January 2016. The meeting's topic is Protein-ligand complexes: understanding biological chemistry, covering aspects of crystallography of protein-ligand complexes from experimental techniques through model building and refinement to structure visualisation and validation. Complementary computational techniques and the use of protein-ligand complex structures will also be discussed. The full programme and registration can be accessed through this link: http://www.ccp4.ac.uk/events/CCP4_2016 Registration opens 7th Sep, early bird registration closes 22nd Nov. Registration closes 14th Dec. Hope to see you next January in Nottingham! the organisers Judit Debreczeni (AstraZeneca, Cambridge, UK) Paul Emsley (MRC LMB, Cambridge, UK) ________________________________ AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 2 Kingdom Street, London, W2 6BD. Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful. Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email. Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking compliance with our Code of Conduct and policies.